Researcher shows that it's not just fatty food which can send bad cholesterol levels soaring - some drinks need to be avoided ...

The company removed experimental drugs for Alzheimer’s, migraine and pain from its pipeline to focus more resources on “core ...

Metabolic syndrome was a risk factor for developing young-onset dementia, along with Alzheimer’s disease and vascular ...

The kitchen cupboard spice could assist in controlling diabetes by lowering blood sugar levels and enhancing metabolic health ...

Zydus Lifesciences rose 1.02% to Rs 897 after the pharma company received final approval from the US Food and Drug Administration (USFDA) to manufacture Niacin Extended-Release Tablets USP, 500 mg , ...

There's a common kitchen spice that's been found to have anti-diabetic properties similar to the blood sugar-lowering medication Metformin.

Zydus Lifesciences Limited has earned USFDA approval for Niacin Extended-Release Tablets used to treat high cholesterol.

According to HCTM upper gastrointestinal and obesity surgeon Associate Prof Datuk Dr Nik Ritza Kosai Nik Mahmood, ESG is emerging as a breakthrough option for obesity management, offering a minimally ...

Review highlights how excessive fructose intake disrupts brain energy balance, appetite regulation, and cognitive function.

A survey of US dermatologists highlights inconsistent screening practices for comorbidities in patients with lichen planus.

Following the recent discontinuations of assets in Alzheimer’s and migraine, AstraZeneca is stepping away from neuro ...